{"id":"W4389338940","doi":"10.1038/s41591-023-02696-8","title":"Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"KRAS; Cetuximab; Medicine; Colorectal cancer; Internal medicine; Oncology; Epidermal growth factor receptor; Adverse effect; Confidence interval; Cancer; EGFR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007281316,0.001408791,0.001428942,0.0003641506,0.0002962521,0.0006716548,0.0005049634,0.001002383,0.003436252],"category_scores_gemma":[0.0004881549,0.0003322756,0.001038862,0.0003198153,0.0005194333,0.0005611709,0.0003288099,0.002330754,0.0005495643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007297467,"about_ca_system_score_gemma":0.00099511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008275585,"about_ca_topic_score_gemma":0.003026973,"domain_scores_codex":[0.9997692,0.00009457654,0.00001393973,0.00004076879,0.00003296184,0.0000485279],"domain_scores_gemma":[0.9996723,0.00004844163,0.00006003351,0.00001786153,0.00003766991,0.0001636651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.788892,0.023678,0.002348786,0.002308732,0.001584778,0.0002738794,0.0002263391,0.003107088,0.03046715,0.0004592709,0.007630137,0.1390237],"study_design_scores_gemma":[0.711997,0.2700047,0.006062099,0.0001273738,0.0005433502,0.0002907103,0.0000646754,0.002262286,0.003257438,0.0003041733,0.005048643,0.00003750729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886517,0.004837512,0.0003795779,0.000774299,0.0002193057,0.001248165,0.0009971429,0.0001416879,0.002750664],"genre_scores_gemma":[0.9801768,0.005072434,0.001639227,0.001555419,0.0002871795,0.001587801,0.003452514,0.0000412345,0.006187405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003436252,"threshold_uncertainty_score":0.01149535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02226460767532055,"score_gpt":0.3907521357749205,"score_spread":0.3684875280995999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}